Results 131 to 140 of about 348,129 (265)

When the River Runs Low: Heterogeneous Impacts of Transportation Disruptions on Local Grain Basis

Agribusiness, EarlyView.
ABSTRACT A substantial share of U.S. soybean and corn exports from the Midwest moves by barge along the Mississippi River system to export terminals in the Louisiana Gulf. Transportation costs between Midwestern grain elevators and export terminals create a wedge between prices at these locations, and shocks to these costs are partially passed on to ...
Yuan Zhang, Andrew E. Anderson, Nicholas J. Pates, Eunchun Park   +3 more
wiley   +1 more source

Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia? [PDF]

Drug Alcohol Rev
Lloyd Z, Roxburgh A.
europepmc   +1 more source

Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs. [PDF]

Healthcare (Basel), 2022
Resiak D, Mpofu E, Rothwell R.
europepmc   +1 more source

Comparison Between Upfront Surgery and Preoperative Chemotherapy for CY1P0 Gastric Cancer: A Japanese Sub‐Analysis of CONVO‐GC‐1

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Radical gastrectomy, followed by adjuvant chemotherapy has been a common practice in Japan for peritoneal lavage cytology‐positive (CY1) but peritoneal dissemination‐negative (P0) stage IV gastric cancer. This study aimed to clarify the differences in treatment outcomes between upfront surgery and preoperative chemotherapy, followed
Kenichiro Furukawa, Itaru Yasufuku, Hironori Ishigami, Masahiro Yura, Takanobu Yamada, Shigeaki Baba, Takeshi Kubota, Erina Nagai, Seito Fujibayashi, Mitsumasa Yoshida, Takahiro Kinoshita, Nobuhisa Matsuhashi, Masanori Terashima   +12 more
wiley   +1 more source

US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis. [PDF]

Harm Reduct J
Broman M, Davis AK, Armstrong S, Levin A, Ahmed K, Angarita GA, Arterberry BJ, Bergeria C, Earleywine M, Gex KS, Gregoire T, Lister JJ, Mathai DS, Mehtani NJ, Menke N, Nichols CD, Shaub H, Tackett AP, Weiss B, Yalin N, Phillips LD.   +20 more
europepmc   +1 more source

Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future. [PDF]

Harm Reduct J, 2021
O'Gorman A, Schatz E.
europepmc   +1 more source

Effect of Broad‐Spectrum Antibiotic Prophylaxis on Post‐Pancreatoduodenectomy Infectious Complications: Nationwide Inpatient Database Study in Japan

Annals of Gastroenterological Surgery, EarlyView.
Using a nationwide Japanese inpatient database, we evaluated whether broad‐spectrum antibiotic prophylaxis improves postoperative outcomes after pancreatoduodenectomy compared with narrow‐spectrum antibiotics. In propensity score–weighted analyses of 45 099 patients, broad‐spectrum prophylaxis was associated with significantly lower rates of intra ...
Hiroki Kitagawa, Shotaro Aso, Yuki Hirano, Kenichiro Uemura, Keita Kouzu, Satoru Matsuda, Hiroki Matsui, Kiyohide Fushimi, Junichi Sasaki, Yuko Kitagawa, Hideo Yasunaga   +10 more
wiley   +1 more source

Counting the savings: impact of Georgia's drug policy interventions on households. [PDF]

Int J Equity Health
Gorgodze T, Zoidze A, Gotsadze G.
europepmc   +1 more source

An ethical analysis of UK drug policy as an example of a criminal justice approach to drugs: a commentary on the short film Putting UK Drug Policy into Focus. [PDF]

Harm Reduct J, 2020
Holland A.
europepmc   +1 more source

National drug policies

The Lancet, 1995
R O, Laing, D G, Ross-Degnan
openaire   +2 more sources